If you are wondering why the pps hasn't moved on v
Post# of 36566
(Total Views: 396)
Posted On: 07/20/2020 11:26:56 PM
If you are wondering why the pps hasn't moved on very interesting/exciting news, look no further than Seeking Alpha. The GNBT story has been up for over 8 hours, and 0 comments. Does this sound like a stock that has many followers (any followers?)?
As contrast, look at CYDY articles on SA. Hundreds to near a thousand comments on various stories. Those folks commenting are also those that are buying the stock, causing the big moves. CEMI doesn't move nearly like CYDY, and the number of comments on their stories show a similar pattern - big news elicits 10 - 15 comments, lesser news 10 or less.
Nobody either knows about GNBT, or its potential, or, they don't care (I think the former, rather than the latter). If we hit the jackpot with BARDA funding, or some other national news event, that will change and I think we'll see our pps mimic some others. And with only 80 to 100 million shares (assume some dilution from the S1 funding deals), we should see steeper jumps than CYDY or other contemporaries. But IMO, nothing is going to happen until that national news event - funding, NGIO listing, or maybe exposure on a national show that is discussing vaccines.
As contrast, look at CYDY articles on SA. Hundreds to near a thousand comments on various stories. Those folks commenting are also those that are buying the stock, causing the big moves. CEMI doesn't move nearly like CYDY, and the number of comments on their stories show a similar pattern - big news elicits 10 - 15 comments, lesser news 10 or less.
Nobody either knows about GNBT, or its potential, or, they don't care (I think the former, rather than the latter). If we hit the jackpot with BARDA funding, or some other national news event, that will change and I think we'll see our pps mimic some others. And with only 80 to 100 million shares (assume some dilution from the S1 funding deals), we should see steeper jumps than CYDY or other contemporaries. But IMO, nothing is going to happen until that national news event - funding, NGIO listing, or maybe exposure on a national show that is discussing vaccines.
(3)
(0)